EARCO stands for European Alpha-1 Research Collaboration. It is a pan-European network committed to promoting clinical research and education in alpha-1 antitrypsin deficiency (AATD). The core project is the International AATD Registry, a collaboration open to all Investigators around the world caring for patients with AATD.
While EARCO has started as a European Network, a number of countries outside of Europe are in the process of joining in.
EARCO has a global vision to increase the early diagnosis of Alpha-1 antitrypsin deficiency (AATD), understand better the natural history of the disease and ensure optimal access to effective care, placing emphasis on ambitions that serve collective needs of the AATD research community and bringing people with AAT deficiency to the centre of the research environment in a real-world context.